Before Aduhelm, Billy Dunn was a superstar at the FDA

Billy Dunn, the regulator at the center of the FDA’s decision on Aduhelm, was a shining star at the agency before that saga, according to new records obtained by STAT.

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

Buckle up: It’s time for the FDA to face another major political test

Read the rest…